<code id='7DB1A5DEBB'></code><style id='7DB1A5DEBB'></style>
    • <acronym id='7DB1A5DEBB'></acronym>
      <center id='7DB1A5DEBB'><center id='7DB1A5DEBB'><tfoot id='7DB1A5DEBB'></tfoot></center><abbr id='7DB1A5DEBB'><dir id='7DB1A5DEBB'><tfoot id='7DB1A5DEBB'></tfoot><noframes id='7DB1A5DEBB'>

    • <optgroup id='7DB1A5DEBB'><strike id='7DB1A5DEBB'><sup id='7DB1A5DEBB'></sup></strike><code id='7DB1A5DEBB'></code></optgroup>
        1. <b id='7DB1A5DEBB'><label id='7DB1A5DEBB'><select id='7DB1A5DEBB'><dt id='7DB1A5DEBB'><span id='7DB1A5DEBB'></span></dt></select></label></b><u id='7DB1A5DEBB'></u>
          <i id='7DB1A5DEBB'><strike id='7DB1A5DEBB'><tt id='7DB1A5DEBB'><pre id='7DB1A5DEBB'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:4
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          10 reasons why health care startups fail
          10 reasons why health care startups fail

          AdobeInourrolesatMedTechInnovator,aglobalacceleratorformedtechstartups,we’veworkedwiththousandsofear

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Biogen walks away from Aduhelm, years after polarizing approval

          JessicaRinaldi/TheBostonGlobeBiogenisgivingupitsownershipofAduhelm,theAlzheimer’sdiseasetreatmentwho